This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jean-Yves Wach: Innovator in Medicinal Chemistry
Introduction
Jean-Yves Wach is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel pharmaceutical compounds. His work focuses on creating innovative solutions that address critical health challenges.
Latest Patents
Jean-Yves Wach holds a patent for Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors. The present invention provides compounds of formula I, wherein R, R', or R'' are as described herein, as well as pharmaceutically acceptable salts thereof. Furthermore, the invention is concerned with the manufacture of these compounds, pharmaceutical compositions comprising them, and their use as medicaments.
Career Highlights
Throughout his career, Jean-Yves Wach has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His expertise in medicinal chemistry has led to advancements in drug development and therapeutic solutions.
Collaborations
He has collaborated with notable colleagues, including Patrick Schnider and Amanda Lee Dupont, to further enhance the impact of his research and innovations.
Conclusion
Jean-Yves Wach's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to improving healthcare through scientific advancements. His work continues to inspire future developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile